Cargando…
Is Salivary S100B a Biomarker of Traumatic Brain Injury? A Pilot Study
Traumatic brain injury (TBI) results in short and long-term disability neurodegeneration. Mild traumatic brain injury (mTBI) represents up to 85% of head injuries; diagnosis and early management is based on computed tomography (CT) or in-hospital observation, which are time- and cost- intensive. CT...
Autores principales: | Janigro, Damir, Kawata, Keisuke, Silverman, Erika, Marchi, Nicola, Diaz-Arrastia, Ramon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303321/ https://www.ncbi.nlm.nih.gov/pubmed/32595592 http://dx.doi.org/10.3389/fneur.2020.00528 |
Ejemplares similares
-
Biomarkers in traumatic brain injury (TBI): a review
por: Dadas, Aaron, et al.
Publicado: (2018) -
Peripheral Blood and Salivary Biomarkers of Blood–Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts
por: Janigro, Damir, et al.
Publicado: (2021) -
Improving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkers
por: Dadas, Aaron, et al.
Publicado: (2016) -
Diagnostic biomarker kinetics: how brain-derived biomarkers distribute through the human body, and how this affects their diagnostic significance: the case of S100B
por: Murcko, Robert, et al.
Publicado: (2022) -
FAIR Data Reuse in Traumatic Brain Injury: Exploring Inflammation and Age as Moderators of Recovery in the TRACK-TBI Pilot
por: Huie, J. Russell, et al.
Publicado: (2021)